Results 211 to 220 of about 231,458 (256)

Optimized monoclonal antibody panel for accurate immunohistochemical detection of haematopoietic cell populations in animal species. [PDF]

BMC Vet Res
Maestre L, Caleiras E, Reyes-García AI, Vega Z, Jiménez S, San Juan-Casero C, González P, Martínez-Nevado E, García-García J, Jiménez-Martínez MLÁ, Pérez-Martínez C, Benavides-Silván J, García-Olmo DC, Largo-Aramburu C, de Molina-Iracheta A, Borragán S, Pulford K, Roncador G.   +17 more
europepmc   +1 more source

Periprocedural Wound Complication Risks in Cancer Pain Patients Following Targeted Cancer Therapy: A Retrospective Analysis

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background In light of the increasing use of advanced operative procedures for cancer pain, it is crucial for pain physicians to understand the unique potential risks associated with multimodal cancer treatments. Aims We aimed to characterize the periprocedural wound healing risk associated with newer targeted cancer therapies in cancer pain ...
Soun Sheen, Vishal Bansal, Xiaowen Sun, Jian Wang, Saba Javed   +4 more
wiley   +1 more source

Targeting glycans for cancer immunotherapy. [PDF]

Nat Biotechnol
europepmc   +1 more source

Sequential Philadelphia‐Positive Pre‐B Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia With Distinct BCR::ABL1 Fusion Transcripts

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background The sequential emergence of chronic myeloid leukemia (CML) following Philadelphia‐positive acute lymphoblastic leukemia (ALL) is exceedingly rare, and its biological basis remains uncertain. Case We report a 15‐year‐old boy initially diagnosed at age 4 with Philadelphia‐positive pre‐B ALL expressing p190 BCR::ABL1.
Atbin Latifi, Sina Yousefian
wiley   +1 more source

Guardians of immunity: the role of tumour-draining lymph node in cancer immunity. [PDF]

Front Cell Dev Biol
Oo D, Sharma I, Xue J, Liao S.
europepmc   +1 more source

Assessment of Selected Immunophenotypic Markers in Childhood Non‐Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Non‐Hodgkin lymphomas (NHL) represent a heterogeneous group of malignancies with varying molecular and immunophenotypic characteristics. In Ghana, NHL is the third most common childhood cancer, highlighting the need for precise diagnostic approaches to improve survival rates.
Samuel Asamoah Sakyi, Bernard Gyan, Ernest Adankwah, Ernest Kwasi Adjei, Vivian Paintsil, David Kwabena Adu, Manu Akwasi Owusu, Clement Binwatin Dagungong, Muniru Mohammed Tanko, Kervin Edinam Zogli, Alfred Effah, Samuel Kwame Sopuruchi Agomuo, Samuel Kwarteng, Beatrice Nyantakyiwaa, Edward Osei Gyimah, Harriet Yeboaa Diawuo, George Oduro Owusu, Ebenezer Senu, Oscar Simon Olympio Mensah, Stephen Opoku, Benjamin Amoani, Linda Ahenkorah Fondjo   +21 more
wiley   +1 more source

Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphoma. [PDF]

Blood Cancer J
Park B, Ryu KJ, Choi MK, Yoon SE, Kim WS, Kim SJ.   +5 more
europepmc   +1 more source

Prophylaxis Strategies for SARS‐CoV‐2 Infection in Adults With Hematological Malignancies in Saudi Arabia: Consensus Statements From the Working Group on COVID‐19 Management in Hematological Malignancies

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Despite the end of the pandemic phase, patients with hematological malignancies (HMs) remain vulnerable to severe COVID‐19 infection and mortality. Prophylaxis strategies, including vaccination and monoclonal antibodies (mAbs) like AZD7442, are crucial for protection.
Mubarak Al‐Mansour, Ayman Alhejazi, Manal Ahmed Alsaggaf, Hafiz Mosa Malhan, Riad El Fakih, Reyad Dada, Ghazi Saud Alotaibi, Reem S. Almaghrabi, Majid Alshamrani   +8 more
wiley   +1 more source

DNA Hypomethylating Agents Preserve T-cell Stemness and Potentiate the Efficacy of CD3-Bispecific Antibodies. [PDF]

Cancer Immunol Res
Aleynick M, Wang Q, Wu JE, Lemus S, Chaimowitz M, Mir H, Warsaw JJ, Guo C, Macdonald LE, Waite JC, Kourtis N, Skokos D.   +11 more
europepmc   +1 more source

Hyperglycemia‐Induced Microglial CTSS Disrupts Blood‐Retinal Barrier Integrity via PAR2‐Dependent Downregulation of Endothelial MFSD2A

CNS Neuroscience &Therapeutics, Volume 32, Issue 10, October 2026.
Hyperglycemia induces retinal microglial activation and CTSS upregulation, disrupting microglia‐endothelial crosstalk via PAR2‐dependent MFSD2A suppression. Abnormal activation of microglia amplifies retinal inflammatory cascade, enhances transcytosis, compromises BRB integrity, and accelerates DR progression.
Chengye Xu, Hongxue Li, Qian Xu, Kangqi Zhao, Yangwen Chen, Yan Wang, Wei Zou, Binglin Kuang, Hongyu Kuang   +8 more
wiley   +1 more source